Back to FRANKLIN TEMPLETON INC FRANKLIN TEMPLETON INC

HRTXHRTX
Showing 4 of 24 quarters

Position history for FRANKLIN TEMPLETON INCFRANKLIN TEMPLETON INC's holdings in HERON THERAPEUTICS INC

No. Franklin Templeton exited its HRTX (Heron Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 77,552 shares worth $170,614. Franklin Templeton already held HRTX in its Q3 2019 13F, the earliest on record, and held it in 23 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$41,217

Total Shares Change

-23,026

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$2.07
0
2025-Q1
Increased
77,552
+236.8%
$170,6140.0%$2.20
25
2024-Q4
Unchanged
23,026
0.0%
$35,2300.0%$1.53
0
2024-Q3
Decreased
23,026
-99.6%
$41,2170.0%$1.99
0

Other major holders of HRTX: FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used